Profil
Brent Zanke is the founder of CTRL Therapeutics, Inc., ArcticDX, Inc. Formerly, Director at Cross Cancer Institute.
Education includes a doctorate from the University of Toronto, conferred in 1993, and a doctorate from the University of Manitoba, conferred in 1983.
Postes actifs de Brent Zanke
| Sociétés | Poste | Début |
|---|---|---|
ArcticDX, Inc.
ArcticDX, Inc. Medical/Nursing ServicesHealth Services Designs molecular diagnostic testing services | Fondateur | - |
Anciens postes connus de Brent Zanke
| Sociétés | Poste | Fin |
|---|---|---|
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood | Directeur Général | - |
Cross Cancer Institute | Directeur/Membre du Conseil | - |
Formation de Brent Zanke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArcticDX, Inc.
ArcticDX, Inc. Medical/Nursing ServicesHealth Services Designs molecular diagnostic testing services | Health Services |
Cross Cancer Institute | |
CTRL Therapeutics, Inc.
CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood | Health Technology |
















